Testing effectiveness (Phase 2)Study completedNCT00053573
What this trial is testing
RhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)
Who this might be right for
Glycogen Storage Disease Type IIPompe DiseaseAcid Maltase Deficiency Disease+1 more
Genzyme, a Sanofi Company 20